ATE191644T1 - Impfstoff gegen infektiöse bursal-krankheit - Google Patents

Impfstoff gegen infektiöse bursal-krankheit

Info

Publication number
ATE191644T1
ATE191644T1 AT93309595T AT93309595T ATE191644T1 AT E191644 T1 ATE191644 T1 AT E191644T1 AT 93309595 T AT93309595 T AT 93309595T AT 93309595 T AT93309595 T AT 93309595T AT E191644 T1 ATE191644 T1 AT E191644T1
Authority
AT
Austria
Prior art keywords
bursal disease
infectious bursal
under
immunizing amount
effective immunizing
Prior art date
Application number
AT93309595T
Other languages
English (en)
Inventor
Bezalel Gutter
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Ltd filed Critical Abic Ltd
Application granted granted Critical
Publication of ATE191644T1 publication Critical patent/ATE191644T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93309595T 1992-12-01 1993-12-01 Impfstoff gegen infektiöse bursal-krankheit ATE191644T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10393992A IL103939A (en) 1992-12-01 1992-12-01 An anti-DBI vaccine in birds containing attenuated live DBI virus

Publications (1)

Publication Number Publication Date
ATE191644T1 true ATE191644T1 (de) 2000-04-15

Family

ID=11064287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93309595T ATE191644T1 (de) 1992-12-01 1993-12-01 Impfstoff gegen infektiöse bursal-krankheit

Country Status (14)

Country Link
US (1) US5804195A (de)
EP (1) EP0600723B1 (de)
KR (1) KR0127116B1 (de)
CN (1) CN1072962C (de)
AT (1) ATE191644T1 (de)
BR (1) BR9304911A (de)
CZ (1) CZ282443B6 (de)
DE (1) DE69328341T2 (de)
ES (1) ES2147557T3 (de)
HU (1) HU214737B (de)
IL (1) IL103939A (de)
PL (1) PL177386B1 (de)
RU (1) RU2126268C1 (de)
ZA (1) ZA938952B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861665A1 (de) * 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Vakzine gegen Infektiöse Bursitis
KR20000056034A (ko) * 1999-02-12 2000-09-15 에릭 발리베 스테이터코일의 와인딩장치
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
EP1722814B1 (de) 2004-03-12 2016-11-09 Zoetis Services LLC Antigene isolate und vakzine des infektiösen bursitis-virus
DE602005024827D1 (de) 2004-09-09 2010-12-30 Novartis Vaccines & Diagnostic Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
CN103143007B (zh) * 2013-02-27 2014-10-01 哈药集团生物疫苗有限公司 一种利用传代鸡胚成纤维细胞制备传染性法氏囊病毒活疫苗的方法
KR101511712B1 (ko) * 2013-04-03 2015-04-13 주식회사 카브 신규 전염성 ｆ낭병 바이러스 ｉｂｄ ｋ7주 및 이를 이용한 전염성 ｆ낭병 백신
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
US10905136B2 (en) 2015-08-14 2021-02-02 Clear H2O, Inc. High throughput process for delivering semi-firm gel for poultry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584055A (en) * 1966-06-18 1971-06-08 Basf Ag Production of butyraldehydes and butanols with a high proportion of linear compounds
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine

Also Published As

Publication number Publication date
EP0600723A3 (de) 1995-01-11
KR940013536A (ko) 1994-07-15
PL177386B1 (pl) 1999-11-30
KR0127116B1 (ko) 1998-04-01
CZ282443B6 (cs) 1997-07-16
ES2147557T3 (es) 2000-09-16
CZ260593A3 (en) 1994-06-15
CN1113158A (zh) 1995-12-13
IL103939A0 (en) 1993-05-13
HU214737B (hu) 2000-03-28
EP0600723A2 (de) 1994-06-08
HU9303369D0 (en) 1994-03-28
RU2126268C1 (ru) 1999-02-20
DE69328341T2 (de) 2000-12-14
BR9304911A (pt) 1994-06-14
EP0600723B1 (de) 2000-04-12
HUT67324A (en) 1995-03-28
CN1072962C (zh) 2001-10-17
DE69328341D1 (de) 2000-05-18
IL103939A (en) 1996-09-12
US5804195A (en) 1998-09-08
PL301253A1 (en) 1994-06-13
ZA938952B (en) 1994-08-02

Similar Documents

Publication Publication Date Title
Snyder Changes in the field status of infectious bursal disease virus
ATE165978T1 (de) Abgeschwächtes, gentechnologisch hergestelltes pseudorabies virus s-prv-155 und seine verwendungen
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
ATE191644T1 (de) Impfstoff gegen infektiöse bursal-krankheit
CA2134835A1 (en) Live in ovo vaccine
IL123264A0 (en) Multi-subtype FIV vaccines
IE780360L (en) Vaccine against "egg drop disease".
EP0626008A4 (en) Vaccine containing acemannan as an adjuvant.
YU65102A (sh) In ovo zaštita protiv infektivnog bronhitisa
JP2655726B2 (ja) ニューカッスル病ウイルス生ワクチン
Ezeokoli et al. Immunosuppression and histopathological changes in the bursa of Fabricius associated with infectious bursal disease vaccination in chicken
RU2761566C1 (ru) Вакцина иммунокомплексная против инфекционной бурсальной болезни птиц из штамма "ВНИВИП"
HU0100908D0 (en) Chicken anaemia viruses of low pathogenicity
NZ243251A (en) Vaccine against marek's disease virus in poultry
Lohr A serological survey for the presence of antibodies to ‘egg-drop-syndrome-1976’adenovirus
AR031405A1 (es) Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
Ritchie et al. Avian polyomavirus vaccine in psittacine birds
EP0954223A4 (de) Veränderter lebender Vogel-Polyomavirus in Papageien

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties